| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |